glutathione pathway to triple negative cancer

glutathione pathway to triple negative cancer depletion and dihydroorotate dehydrogenase inhibition actuated ferroptosis-augment surmount triple-negative breast Salidroside sensitizes Triple-negative breast cancer

Name: glutathione pathway to triple negative cancer depletion and dihydroorotate dehydrogenase inhibition actuated ferroptosis-augment surmount triple-negative breast Salidroside sensitizes Triple-negative breast cancer
Brand: lcog.de
SKU: 65923273031
Price: 26.12 USD
Availability: InStock
Rating: 4.839700000000001 (20 reviews)

Salidroside sensitizes Triple negative breast cancer to ferroptosis by SCD1 mediated lipogenesis and NCOA4 mediated ferritinophagy ScienceDirect Targeting Glutathione Metabolism: Partner in Crime in Anticancer Therapy Excessive glutathione intake contributes to chemotherapy resistance in breast cancer: a propensity score matching analysis World Journal of Surgical Oncology Springer Nature Link Metabolic reprogramming in triple negative breast cancer PMC Dual metabolic targeting liposomes potentiate triple negative breast cancer radiosensitivity via glucose and glutathione starvation ScienceDirect

SKU: 65923273031 · From lcog.de

4.8

USD26.12 USD73.12

Pay in 4 interest-free payments of $6.53 Learn more